Caesarstone 矽肺诉讼第7起 bellwether 判决:单案分摊4,650万美元,接近800起案件总拨备5,120万、占市值58%
一手SEC披露确认4,650万美元单案分摊(占市值约58%、占净现金约92%),而800起待决案件总拨备仅5,120万美元,公司明确提示融资需求,构成直接、实质、可量化的公司级利空,满足做空红线;但先例显示该股判决后曾发生+30%逼空、盘口极薄且盘前-10%已被买回,故仅给小仓做空。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
分时走势
做空 CSTE.US Caesarstone Ltd.
10-27 盘中或未补齐(盘中约每 15 分钟更新) · 10-28、10-29 尚未交易 · 美股含盘前盘后(灰底:美东 04:00 至收盘后 4 小时) · 10-27 仅常规时段(盘前盘后数据未就绪)
- 发布 10-27 20:59 北京(美东 10-27 08:59)
- 抓取 10-27 21:00 北京(美东 10-27 09:00)
- 决策 10-27 21:45 北京(美东 10-27 09:45)
时间轴只含交易时段(午休、隔夜已压缩);横轴为北京时间,悬停看当地时间;蓝虚线 = 纸面入场价;建仓日图红线在昨收上方、绿线在下方
成交明细 · 纸面
做空 CSTE.US Caesarstone Ltd.
| 收益状态 | 逾期 盘前盘后行情未就绪 |
|---|---|
| 进场成交 | — |
| 离场成交 | — |
| 建仓日 | 2026-10-27 · 进场不早于新闻时刻 + 2 分钟 |
收益口径 event_time_plus_2min_10min_walk_open_topup_to_next_open_exchange_calendar_fill_model_local_notional_v9 · method_id m8db1cbc8f2d · 截至 2026-10-27 22:56
研究档案
结论摘要
一次败诉分摊额(4,650万)≈覆盖800起案件的全部拨备(5,120万)和几乎全部净现金(5,040万),公司自身提示需额外融资,股权清算价值与持续经营预期被实质下修;但CSTE是低价微盘、历史判决后曾逼空暴涨,故小仓试空、严设止损。
消息传播链
- 10-26陪审团作出裁决:总赔偿6,730万,Caesarstone分摊69.1%约4,650万;公司称正考虑救济措施
- 公司盘前法定披露判决金额与过错比例,并在风险提示中提及判决对财务的影响及额外融资能力,为市场首次获得公司确认口径市场反应:盘前最低2.12(-9.8%),09:40回升至2.32(-1.3%),开盘10分钟成交约2.8万美元,盘口极薄
关键理由
- 单案分摊4,650万美元≈公司总诉讼拨备5,120万(覆盖约800起待决索赔),拨备充足性被这一最高单笔判决击穿,后续拨备追加与和解压力将实质压向约8,000万美元市值的股权
- 分摊额约为净现金5,040万的92%,公司在6-K前瞻性陈述中首次明确提示额外融资需求,叠加经营亏损(PE为负)与关税逆风,存在流动性/稀释风险重估
主要风险
- 逼空与波动风险极高:2026-08-04第4次判决后CSTE五个交易日反涨30%,该股日波幅常达10-15%、盘口价差约5%,盘前一度-10%后全数收回,短线可能无视基本面逼空
- 上诉、法官削减赔偿(remittitur)或保险赔付可能显著降低实际现金支出,若公司披露保险覆盖或有利和解,利空逻辑被削弱
反向证据
- 做空前查反向 · 来源 web · 日期 2026-10-23 · 影响 weakens
公司持续表示将抗辩/上诉,历史披露中保险范围存在争议且可能有回收;陪审团判决非最终金额,remittitur/和解可能降低实际支出
检索:Caesarstone 保险覆盖 上诉 削减赔偿 silicosis insurance appeal 原文 ↗ - 做空前查反向 · 来源 kb_search · 日期 2026-08-06 · 影响 weakens
Q2电话会纪要:约800起索赔已计提5,120万拨备、净现金5,040万,二季度多项案件获有利结果且原计划Q3转正调整后EBITDA;多头可主张拨备已充分、最坏情形已计入
检索:Caesarstone 800起 拨备 5120万 净现金 二季度 财报电话会 - 做空前查反向 · 来源 web · 日期 2026-10-27 · 影响 weakens
第4案后5日+30%、本次盘前-10%后全数收回,bid/ask仅100股×1股、价差约5%,流动性与逼空风险对做空高度不利
检索:CSTE 判决后股价反应 逼空
先例如何影响了这次决策
对本次决策的影响:将做空仓位从normal降至small、止损放宽至-12%以容纳逼空噪音、时限设5个交易日而非短线1-2日,并把置信度限制在5
方向:两条对齐先例方向不一致:第4案后5日反涨30%(逼空),第6案后1-2日小跌约3%;胜率与方向参考价值弱,不能作为稳定做空胜率依据
涨幅量级:无一条通过干净锚校验(均有锚前10%级异动、且为盘后发布),decision_grade n=0、样本very_thin,不用先例校准止盈幅度;TP基于本次基本面量级(分摊额≈市值58%)而非先例
形态:关键模式是微盘逼空风险:判决后可以无视利空连续暴涨,叠加盘口极薄,做空必须小仓并给较宽止损
历史先例(按相似度)
- 相似度 7/10 CSTE 2026-10-22 第6次bellwether判赔3,300万,Caesarstone实体为被告;事件前一周股价大幅震荡(+15%/-10%) 原文 ↗
事件后 +1日 -2.9% · +2日 -2.5%
⚠锚前1-2日已异动10.1%>锚定日2.9%·未核对目标相位 — 该行涨幅别用来定止盈止损
相似度依据:同一公司同一程序的最近一次bellwether(第6案,33M),市场环境与持仓结构最接近,但总判赔与公司分摊额均小于本次4,650万
经验:最近一次判决后首日-2.9%、次日-2.5%,利空方向兑现但幅度有限,市场对诉讼新闻已有部分钝化 - 相似度 6/10 CSTE 2026-08-04 第4次人造石矽肺bellwether,陪审团判赔逾4,700万,Caesarstone为被告之一;锚前两日已涨约10% 原文 ↗
事件后 +1日 +0.7% · +2日 -4.6% · +3日 -0.2% · +4日 +10.6% · +5日 +30.1%
⚠锚前1-2日已异动10.3%>锚定日0.7%·未核对目标相位 — 该行涨幅别用来定止盈止损
相似度依据:同一公司、同一JCCP协调程序、同类矽肺bellwether判决,但总判赔47M的公司分摊额未披露且小于本次,且为盘后发布
经验:判决并非线性利空:第4案后首日+0.7%、第5日+30%(微盘逼空),做空必须承受反身性轧空风险
工具执行结果 · 成功 9 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 505 ms
{"result": "search_processed_events:agent query=`caesarstone 6-k jccp 5378 silica lawsuit liability | caesarstone jury verdict silicosis rivas-williams $67 million | 凯撒石 矽肺 判决 6730万 69.1%`;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 71.4/72 小时、5821 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选,不能据此证明消息首发或不是重复;按当前事 - stock_quote 成功 stock_tools HTTP · 1,656 ms
{ - web_search 成功 doubao_search · 1,909 ms
豆包搜索结果(原始查询:Caesarstone Rivas-Williams silicosis verdict $67 million Los Angeles jury October 2026;API SearchType:web) - web_search 成功 doubao_search · 1,523 ms
豆包搜索结果(原始查询:Caesarstone silicosis verdict list trials 2024 2025 first second third jury award date JCCP 5378;API SearchType:web) - web_search 成功 doubao_search · 1,982 ms
豆包搜索结果(原始查询:Rivas-Williams Caesarstone verdict October 26 2026 silicosis $67 million reaction;API SearchType:web) - kb_search 成功 stock_tools HTTP · 8,971 ms
{ - web_search 成功 doubao_search · 1,923 ms
豆包搜索结果(原始查询:Caesarstone silicosis verdict 2024 2025 "first trial" OR "second trial" OR "third trial" jury million PRNewswire Brayton Purcell;API SearchType:web) - web_search 成功 doubao_search · 1,723 ms
豆包搜索结果(原始查询:Brayton Purcell "$47 million" fourth artificial stone silicosis trial Caesarstone August 2026;API SearchType:web) - event_study 成功 stock_tools HTTP · 35 ms
{
原文全文
展开原文 · 3,218 字
6-K
1
zk2636268.htm
6-K
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of October 2026
Commission File Number: 001-35464
Caesarstone
Ltd.
(Translation of registrant’s name into English)
Kibbutz Sdot Yam
MP Menashe
Israel 3780400
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F
☒
Form 40-F
☐
EXPLANATORY NOTE
As previously disclosed, Caesarstone Ltd. (the
“Company”) and its subsidiaries, including Caesarstone USA, Inc., are defendants in multiple lawsuits alleging that fabricators
contracted illnesses, including silicosis, through exposure to silica particles while fabricating the Company’s products.
On October 26, 2026, the jury rendered a verdict
in one such case brought in the Superior Court of California, County of Los Angeles,
Dennys Rene Rivas-Williams v. A&A Granite
Marble, et al.
(Case No. 23STCV08523), which is part of the coordinated silicosis proceeding (JCCP 5378). The jury found the Company
liable and awarded the plaintiff approximately $67.3 million in damages. The Company was apportioned 69.1% of the fault, or approximately
$46.5 million, if assessed without modification.
The Company is considering its available actions.
This Form 6-K is incorporated by reference into
the Company’s Registration Statements on Form S-8 (Files Nos. 333-180313, 333-210444, 333-251642 and 333-295843).
Cautionary Statement Regarding Forward-Looking
Statements
This Report on Form 6-K contains “forward-looking
statements” within the meaning of federal securities laws. Words such as “believe,” “expect” and “intend”
and similar expressions identify forward-looking statements, which include but are not limited to statements related to the Company’s
expectations regarding post-trial remedies, an appeal and the ultimate outcome of the referenced lawsuit and other pending claims, the
impact of the verdict on the Company’s financial condition and prospects, and the Company’s ability to obtain additional financing.
This information is qualified in its entirety by the risks and uncertainties discussed under the sections “Risk Factors” and
“Special Note Regarding Forward-Looking Statements and Risk Factor Summary” in the Company’s most recent annual report
on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on March 4, 2026, and in other documents filed
by the Company with the SEC, which are available free of charge at www.sec.gov. These forward-looking statements are made only as of the
date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information,
future events or otherwise.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CAESARSTONE LTD.
Date: October 27, 2026
By:
/s/ Nahum Trost
Name: Nahum Trost
Title: Chief Financial Officer
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
ff72bfd401· 2026-10-27 21:45 · doubao / doubao-seed-evolving-latest-version · 策略包2cd9474a9f7b当前